Go to myHPBInternational Hepato-Pancreato-Biliary Association
15th IHPBA World Congress - New York , United States
March 31st - April 2nd, 2022
15th IHPBA World Congress
-
DEB01: Open vs Robotic; PDAC with Vascular Involvement
Debate 01: Open vs Robotic; PDAC with Vascular Involvement
-
DEB02: Chemotherapy Should Always be Given Prior to Liver Surgery for CRLM? Pro/Con
Debate 02: Chemotherapy Should Always be Given Prior to Liver Surgery for CRLM? Pro/Con
-
DEB03: Resection of Oligo Metastatic Liver Disease in Pancreatic Cancer Patients: Yes/No
Debate 03:Resection of Oligo Metastatic Liver Disease in Pancreatic Cancer Patients: Yes/No
-
DEB04: Failed PVE ALPPS vs Hepatic Vein Embolization
Debate 04: Failed PVE ALPPS vs Hepatic Vein Embolization
-
DEB05: Acute Cholecystitis: Up-Front vs. Delayed Cholecystectomy
Debate 05: Acute Cholecystitis: Up-Front vs. Delayed Cholecystectomy
-
DEB06 Minimally Invasive Surgery - Is it Worth Learning Late in Life? Yes/No
Debate 06: Minimally Invasive Surgery - Is it Worth Learning Late in Life? Yes/No
-
DEB07: Synchronous Liver Metastases and Rectal Carcinoma Sequential vs Simultaneous
Debate 07: Synchronous Liver Metastases and Rectal Carcinoma Sequential vs Simultaneous
-
DEB08: Routine Enteral Tube Feeding vs Oral Feeding (Nutrition after Pancreatoduodenectomy)
Debate 08: Routine Enteral Tube Feeding vs Oral Feeding (Nutrition after Pancreatoduodenectomy)
-
DEB09: HCC Macrovascular Invasion Resection
Debate 09: HCC Macrovascular Invasion Resection
-
DEB10: Advanced CRLM: HAI Pump vs Transplant
Debate 10: Advanced CRLM: HAI Pump vs Transplant
-
DEB11: Robot Fellowship Training is Essential Yes or No
Debate 11: Robot Fellowship Training is Essential Yes or No
-
DEB12: Minimal Access for HBDca: Yes/No
Debate 12: Minimal Access for HBDca: Yes/No
-
DEB13: Preferred Local Regional Therapy for Margin Sterilization Intraoperative Radiotherapy vs IRE
Debate 13: Preferred Local Regional Therapy for Margin Sterilization Intraoperative Radiotherapy vs IRE
-
DEB14: Aggressive Liver Surgery for Locally Advanced Cancer: Is there a role or not?
Debate 14: Aggressive Liver Surgery for Locally Advanced Cancer: Is there a role or not?
-
DEB15: Neoadjuvant Therapy for Resectable Pancreas Cancer: Yes/No
Debate 15: Neoadjuvant Therapy for Resectable Pancreas Cancer: Yes/No
-
DEB16: Donor Hepatectomy Laparoscopic vs Open
Debate 16: Donor Hepatectomy Laparoscopic vs Open
-
DEB17: Hepatic Adenoma: Time for Expanding the Conservative Management? Yes/No
Debate 17: Hepatic Adenoma: Time for Expanding the Conservative Management? Yes/No
-
DEB18: Bridge/Downstaging in HCC: Y90 vs SBRT vs TACE
Debate 18: Bridge/Downstaging in HCC: Y90 vs SBRT vs TACE
-
KN01: Palliative Liver Resection
Keynote Lecture 01: Palliative Liver Resection
-
KN02: Contemporary Management of Hilar Cholangiocarcinoma
Keynote Lecture 02: Contemporary Management of Hilar Cholangiocarcinoma
-
KN03: An Ideal Liver Graft Machine Profusion
Keynote Lecture 03: An Ideal Liver Graft Machine Profusion
-
KN04: IPMN Treatment Guidelines Update
Keynote Lecture 04: IPMN Treatment Guidelines Update
-
KN05: Management of Choledochal Cysts
Keynote Lecture 05: Management of Choledochal Cysts
-
KN07: Pancreatic Cancer Surgery: Evidence and Future
Keynote Lecture 07: Pancreatic Cancer Surgery: Evidence and Future
-
KN08: Liver Resection in Advanced HCC
Keynote Lecture 08: Liver Resection in Advanced HCC
Filter videos
Corporate Partners
If you are interested in becoming a Corporate Partner of the IHBPA please contact industry@ihpba.org
Find out more
